We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

113 hedge funds and large institutions have $583M invested in MacroGenics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 29

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

37% more call options, than puts

Call options by funds: $824K | Put options by funds: $600K

6% more capital invested

Capital invested by funds: $548M → $583M (+$34.7M)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding

Funds holding: 113 → 113 (0)

3.66% less ownership

Funds ownership: 89.48% → 85.82% (-3.7%)

Holders
113
Holders Change
–
Holders Change %
0%
% of All Funds
2.82%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
12
Increased
48
Reduced
29
Closed
11
Calls
$824K
Puts
$600K
Net Calls
+$224K
Net Calls Change
+$479K

Top Buyers

Rank Fund Capital Flow
1
PA
Pinnacle Associates
New York
+$4.05M
2
VOYA Investment Management
VOYA Investment Management
Georgia
+$2.45M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.24M
4
SFM
Sphera Funds Management
Israel
+$2.21M
5
BG
Bellevue Group
Switzerland
+$2.02M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.5M
2
EOJOAM
E. Ohman J:or Asset Management
Sweden
-$3.45M
3
AG
Artal Group
Luxembourg
-$1.73M
4
MWNA
Marshall Wace North America
New York
-$1.47M
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$1.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$81.4M -$14.5M -834,393 -16%
O
2
OppenheimerFunds
New York
$65.6M -$586K -33,817 -0.9%
BlackRock
3
BlackRock
New York
$49.8M +$1.59M +91,904 +4%
BB
4
BB Biotech
Switzerland
$44.4M +$871K +50,300 +2%
BC
5
Boxer Capital
California
$40.7M +$1.47M +85,000 +4%
Vanguard Group
6
Vanguard Group
Pennsylvania
$28.1M +$2.24M +129,085 +9%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$21.8M +$1.68M +96,900 +9%
IVM
8
InterWest Venture Management
California
$19.9M – – –
WA
9
Wasatch Advisors
Utah
$19.3M -$208 -12 -0%
State Street
10
State Street
Massachusetts
$18.6M +$606K +34,996 +4%
PA
11
Pinnacle Associates
New York
$15.6M +$4.05M +233,657 +38%
HRCM
12
Hood River Capital Management
Florida
$10.9M +$218K +12,606 +2%
VOYA Investment Management
13
VOYA Investment Management
Georgia
$9.3M +$2.45M +141,512 +39%
Franklin Resources
14
Franklin Resources
California
$9.28M – – –
EA
15
Emerald Advisers
Pennsylvania
$8.23M -$157K -9,050 -2%
BG
16
Bellevue Group
Switzerland
$8.01M +$2.02M +116,881 +37%
Northern Trust
17
Northern Trust
Illinois
$7.95M -$43.6K -2,515 -0.6%
UBS AM
18
UBS AM
Illinois
$6.86M -$7.36K -425 -0.1%
BBA
19
Baker Bros. Advisors
New York
$6.72M – – –
EMFAT
20
Emerald Mutual Fund Advisers Trust
Pennsylvania
$6.62M – – –
TA
21
Teachers Advisors
New York
$5.97M +$11.1K +643 +0.2%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$5.46M +$186K +10,715 +4%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$5.24M +$1.78M +102,778 +57%
TM
24
Tiger Management
New York
$4.43M – – –
RSCM
25
Rock Springs Capital Management
Maryland
$4.16M – – –
1
2 3 4 5

MGNX Hedge Fund Activity: Q3 2017 in Review

113 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2017, worth a combined $583M — up 6.3% from $548M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MGNX positions and 11 closed out — a net gain of 1 holder — while 48 added to existing stakes and 29 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $4.05M. The largest seller was Fidelity Investments, cutting an estimated $14.5M.

  • 113 institutional investors held MacroGenics (MGNX) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $583M of MacroGenics stock for Q3 2017, up 6.3% quarter-over-quarter.
  • 12 funds opened new MacroGenics positions in Q3 2017 and 11 closed out, a net change of +1 holder.
  • The largest MacroGenics buyer in Q3 2017 was Pinnacle Associates, an estimated $4.05M added.
  • The largest MacroGenics seller in Q3 2017 was Fidelity Investments, an estimated $14.5M sold.

Based on aggregated 13F filings for Q3 2017.